Notities
Diavoorstelling
Overzicht
1
Complications of
Hip Surgery
2
Special Problems in RA
  • Polysystemic
  • Polypharmacy
  • Polyarticular
  • Creeping substitution
  • Rehab difficult
  • Death (SMR1.48)
    Lie Acta Orth Scand 2000 71 19-27
  • Anaemia
    Epo Matsuda et al Orthopaedics 24(1) 41-4 2001
3
Complications of Hip Replacement Surgery
  • Thromboembolism
  • Dislocation
  • Heterotopic ossification
  • Aseptic Loosening
  • Sepsis
4
Complications
  • Thromboembolism
    13% bleeding with LMWH
    Van Heereveld et al Ann Rheum Dis 60(10) 974-6 2001
  • Dislocation No difference
    (Scottish Arthroplasty Project)
  • Heterotopic ossification
    Lower in RA
    Eggli Arch Orthop Trauma Surg 2001 121 (9) 531-5
5
Aseptic Loosening
  • Initial interlock
  • Bone metabolism
  • 79 % survival at 25 years
    (Sochart/Porter1998 Lehtimaki J Arth 199 14 657-61)
  • Increased loosening
    Ahnfelt Acta Orth Scand 1990 61 238 1-26 (Swedish Arth Register)
  • No Difference
    Furnes JBJS 83B 2001 579-586                   (Norwegian Arth Register)
6
Revision for Aseptic Loosening
  • Acetabulum 2.6 – 8.4%
  • Femur          OA = RA
  • RA worse than OA
    but age correction equal
7
 
8
Cemented Femoral Failure in RA
  • 2% aseptic femoral loosening 10 Years
    Creighton et al JBJS A 80 1439 1998 (Iowa)
  • 10% femoral loosening at 15 years
    Lehtimaki et al J Arth 14 657 1999 (Finland)
  • 15% aseptic femoral loosening 25 years
    Sochart Porter JBJS A 79 1599 1997 (Wrightington)


9
Uncemented?
  • Osteoporosis
  • Cups good
    Stems poor
    Thomasen J Arth 16(5) 628-34 2001
  • Stems Promising
    Keisu J arth 2001 16 415-21
  • “Excellent”
    Effenberger Arch Orth Tr Surg 2002 122 80-7
  • Failure dependant on implant
    Schroeder-Boersch Orthopaede 1998 27 333-40


10
Protrusio
  • Reconstruct centre of rotation
  • Better interface
  • Medialised   loosening (Poss 1984)
11
Cemented Femoral revision in RA
  • 45/47 “secure” 4% failure at 7 years
    Raut et al JBJS B 76 909 1994
  • 6.9% failure at 8.5 years (type 2 femurs)
    Pierson Harris JBJS B 76 40 1994


12
Acetabular revision
  • 90% survival 8 years impaction grafting
    Schreurs JBJS A 2003 85 647-52
  • Uncemented low risk surviving
     44% at 8 yrs
    Mont Clin Orth 2002 400 140-8
  • Cement “not very encouraging”
    Raut JBJS A  78 1853-6
13
Complications Infection
  • Early deep 1.8 x OA
    Poss et al Clin Orth 182 109
  • 2-4 x late
    Freeman et al Clin Orth 95: 224
  • Immunosuppression
  • Acute pre op infection
  • “No difference”
    Scottish Arthroplasty report 2004
    Espehaug Acta Orth Scand 1997 68 207-15
14
DMARDS and Infection
  • Alone  small increase in infections
    but are life threatening
    Moreland Pharmacoeconomics 2004 22 39-53
    Phillips Arthitis Rheum 2002 47 17-21
  • Combinations additive
    Hansen Arthritis Rheum 2004 15 51 228-32
  • Primary no evidence for stopping
    Hip
    Foot Bibbo; Foot Ankle 2004 25 331-5
  • Revisions - discontinue
15
Diagnosis Of Infection in RA
  • 52 RA revisions
    9 infected Hansen protocol
  • ESR >30
    30% infected
    ESR<30
    95% not infected
  • CRP >20
    25% infected
    CRP> 20
    90%  not infected
  • Aspiration
    Positive  100% infected
    Negative 70% not Inf
16
Diagnosis Of Infection in RA
  • Histology
    +ve 50% Infected
    -ve 95% not Inf
  • PCR
    +ve 25% infected
    -ve 90% not Inf


17
Radiographic changes
  • Periosteal reaction
    Fitzgerald RH  Orth Clin N Am 1992 23 259-64
  • Early osteolysis
    Huddlestone HD J Arth 1988 3 285-97
  • 91% loosening
    Lyons CW Clin Orthop 1985 195 239-51
18
Imaging
  • Tech/Ind Bone scan 79% Sens 83% Spec
    Itasaka T J Orthop Sci 2001 6(4) 320-6
    -ve rules out infection Terhanzedeh J Clin Nuc Med 1988 13 229-36
  • Indium WCC scan 80% Sens 100% spec
    Oyen et alJ Nuc Med 32 1991 1854-60
  • FDG Pet scan Sens 90% Spec 89%
    Zhuang H J Nuc Med 2001 42 44-8


19
Imaging 2
  • Ultrasound all have effusions
    AJ Radiology 1994 163 (2) 381-4
  • MRI “routine use not supported by data”
    Joseph TN J Arth 2001 16(6) 753-8
  • Labelled Cefuroxime 85% Sens 92% spec
    Yafar Z Eur J Nuc Med 2001 28(7) 822
20
Diagnostic Summary
  • Negative inflammatory markers helpful
  • Imaging unhelpful (other than radiograph)
  • Positive aspiration microbiology good
  • Negative histology useful
  • PCR no better than existing tests
  • Suspicion



21
Infection “Staging Systems”
  • Organism
  • Time and timing
  • Host response
    2 or more (Diabetes; Cardiac; Tobacco; Immune suppression etc)
  • Limb viability
22
Practical…………………….
+ve intra op culture
  • 6 weeks antibiotics
23
Practical……………………
Early well fixed
  • Debridement
  • Antibiotics
24
Results..Suppresive antibiotics
  • 50% retained for 3 years
  • Medically unfit
  • Physically unfit
  • Known organism
25
Results….Debridement
  • 71% success if< 1 month
  • Early
  • Well fixed
  • Uncemented results poor


26
Practical……………………..
Loose / Late
  • 2 stage + spacer
  • ?1 stage
27
Results .. 1 Stage revision
  • 82% success
  • Radical debridement
  • Sensitive organism
  • Prolonged antibiotics
  • Cemented
  • Cost effective
28
Results ..2 Stage
  • 91% success
29
Results .. 2 Stage + spacer
  • 91% success
  • Resistant organism
  • Loose hip
  • ? Reimplant time
30
Interprosthetic Fracture
  • Internal fixation “all fail”
    Kenny J Arthroplasty 1998 13 361-4
  • Bone metabolism
    Fatigue or trauma?
  • Listen to the bones
31
Conclusion

  • Reconstruction may be necessary
  • Late infection more common
    Difficult to diagnose
  • Disease process as well
    as mechanical failure